Harbin Pharmaceutical Group Co., Ltd.SSE: 600664

Announcement on Severe Abnormal Fluctuations in Stock Trading and Risk Warning

· Issued by Harbin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Summary by 6ix AI

Harbin Pharmaceutical Group Co., Ltd. has issued a warning regarding severe abnormal fluctuations in its stock trading, indicating a significant increase in stock price over a recent period. The company confirms that there are no undisclosed significant matters affecting its stock price and urges investors to assess trading risks carefully. The board of directors assures that the announcement contains no false or misleading information and takes legal responsibility for its accuracy.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Severe Abnormal Fluctuations in Stock Trading and Risk Warning

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Harbin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Harbin Pharmaceutical

Later from Harbin Pharmaceutical

All Harbin Pharmaceutical news releases